Alzheimer’s patient gets back speech, bladder control and memory in groundbreaking drug trial

Key Points:

• An 80-year-old woman with advanced Alzheimer's disease showed remarkable temporary improvements in speech, continence, mobility, and social interaction after receiving a single dose of psilocybin, the psychedelic compound in magic mushrooms.
• The case study, published in Frontiers in Neuroscience, revealed that the patient, previously severely impaired, began speaking in full sentences and regained some lost functions within hours to weeks following the treatment.
• Despite these improvements, the researchers emphasized that psilocybin did not reverse the underlying neurodegeneration, and the benefits were temporary; the exact duration of the effects was not specified.
• The study highlights the potential of psilocybin to access brain functions considered permanently lost in late-stage dementia, though the findings are limited by the single-patient model.
• Psilocybin is known to promote new brain connections and activate serotonin receptors, with prior research indicating long-lasting relief from depression, but it also carries risks such as the possibility of distressing hallucinations during a "bad trip."